Analysis of GPRC6A variants in different pancreatitis etiologies.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 22 05 2020
revised: 09 07 2020
accepted: 02 08 2020
pubmed: 30 8 2020
medline: 18 9 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

The G-protein-coupled receptor Class C Group 6 Member A (GPRC6A) is activated by multiple ligands and is important for the regulation of calcium homeostasis. Extracellular calcium is capable to increase NLRP3 inflammasome activity of the innate immune system and deletion of this proinflammatory pathway mitigated pancreatitis severity in vivo. As such this pathway and the GPRC6A receptor is a reasonable candidate gene for pancreatitis. Here we investigated the prevalence of sequence variants in the GPRC6A locus in different pancreatitis aetiologies. We selected 6 tagging SNPs with the SNPinfo LD TAG SNP Selection tool and the functional relevant SNP rs6907580 for genotyping. Cohorts from Germany, further European countries and China with up to 1,124 patients and 1,999 controls were screened for single SNPs with melting curve analysis. We identified an association of rs1606365(G) with alcoholic chronic pancreatitis in a German (odds ratio (OR) 0.76, 95% confidence interval (CI) 0.65-0.89, p = 8 × 10 Our results support a potential role of calcium sensing receptors and inflammasome activation in alcoholic chronic pancreatitis development. As the functional consequence of the associated variant is unclear, further investigations might elucidate the relevant mechanisms.

Sections du résumé

BACKGROUND BACKGROUND
The G-protein-coupled receptor Class C Group 6 Member A (GPRC6A) is activated by multiple ligands and is important for the regulation of calcium homeostasis. Extracellular calcium is capable to increase NLRP3 inflammasome activity of the innate immune system and deletion of this proinflammatory pathway mitigated pancreatitis severity in vivo. As such this pathway and the GPRC6A receptor is a reasonable candidate gene for pancreatitis. Here we investigated the prevalence of sequence variants in the GPRC6A locus in different pancreatitis aetiologies.
METHODS METHODS
We selected 6 tagging SNPs with the SNPinfo LD TAG SNP Selection tool and the functional relevant SNP rs6907580 for genotyping. Cohorts from Germany, further European countries and China with up to 1,124 patients and 1,999 controls were screened for single SNPs with melting curve analysis.
RESULTS RESULTS
We identified an association of rs1606365(G) with alcoholic chronic pancreatitis in a German (odds ratio (OR) 0.76, 95% confidence interval (CI) 0.65-0.89, p = 8 × 10
CONCLUSIONS CONCLUSIONS
Our results support a potential role of calcium sensing receptors and inflammasome activation in alcoholic chronic pancreatitis development. As the functional consequence of the associated variant is unclear, further investigations might elucidate the relevant mechanisms.

Identifiants

pubmed: 32859544
pii: S1424-3903(20)30650-5
doi: 10.1016/j.pan.2020.08.001
pii:
doi:

Substances chimiques

GPRC6A protein, human 0
Receptors, Calcium-Sensing 0
Receptors, G-Protein-Coupled 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1262-1267

Informations de copyright

Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflicts of interest.

Auteurs

Tom Kaune (T)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Claudia Ruffert (C)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Nico Hesselbarth (N)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Marko Damm (M)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Sebastian Krug (S)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Julian Cardinal von Widdern (J)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Emmanuelle Masson (E)

Univ Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France; CHRU Brest, Service de Génétique Médicale et de Biologie de la Reproduction, Brest, France.

Jian-Min Chen (JM)

Univ Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France.

Vinciane Rebours (V)

Department of Gastroenterology and Pancreatology, Beaujon Hospital, APHP, Clichy, and Paris-Diderot University, Paris, France.

Louis Buscail (L)

Service de Gastroentérologie et Pancréatologie, CHU Toulouse, Toulouse, France.

Claude Férec (C)

Univ Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France; CHRU Brest, Service de Génétique Médicale et de Biologie de la Reproduction, Brest, France.

Robert Grützmann (R)

Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Chirurgische Klinik, Erlangen, Germany.

Rene H M Te Morsche (RHM)

Department of Gastroenterology and Hepatology, Radboud umc, Nijmegen, the Netherlands.

Joost Ph Drenth (JP)

Department of Gastroenterology and Hepatology, Radboud umc, Nijmegen, the Netherlands.

Giulia Martina Cavestro (GM)

Gastroenterology and Gastrointestinal Endoscopy Unit, Division of Experimental Oncology, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy.

Raffaella Alessia Zuppardo (RA)

Gastroenterology and Gastrointestinal Endoscopy Unit, Division of Experimental Oncology, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy.

Adrian Saftoiu (A)

Department of Internal Medicine and Gastroenterology, University of Medicine and Pharmacy, Craiova, Romania.

Ewa Malecka-Panas (E)

Department of Digestive Tract Diseases, Medical University of Łódź, Łódź, Poland.

Stanislaw Głuszek (S)

Collegium Medicum (Medical College), Jan Kochanowski University, Kielce, Poland.

Peter Bugert (P)

Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service of Baden-Württemberg, Mannheim, Germany.

Markus M Lerch (MM)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

Matthias Sendler (M)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

Frank Ulrich Weiss (FU)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

Wen-Bin Zou (WB)

Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China; Shanghai Institute of Pancreatic Diseases, Shanghai, China.

Shun-Jiang Deng (SJ)

Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China; Shanghai Institute of Pancreatic Diseases, Shanghai, China.

Zhuan Liao (Z)

Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China; Shanghai Institute of Pancreatic Diseases, Shanghai, China.

Markus Scholz (M)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; LIFE- Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Holger Kirsten (H)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; LIFE- Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Peter Hegyi (P)

Institute for Translational Medicine and First Department of Internal Medicine, Medical School, University of Pécs, Pécs, Hungary; First Department of Medicine, University of Szeged, Szeged, Hungary.

Heiko Witt (H)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin (EKFZ), Paediatric Nutritional Medicine, Technische Universität München (TUM), Freising, Germany.

Patrick Michl (P)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Heidi Griesmann (H)

Department of Internal Medicine I, Martin Luther University, Halle, Germany.

Jonas Rosendahl (J)

Department of Internal Medicine I, Martin Luther University, Halle, Germany. Electronic address: jonas.rosendahl@uk-halle.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH